chr12-109792401-A-G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PP2PP3_StrongPP5_Moderate
The NM_021625.5(TRPV4):c.1853T>C(p.Leu618Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_021625.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Metatropic dysplasia Pathogenic:2
- -
- -
not provided Pathogenic:1
The L618P pathogenic variant in the TRPV4 gene has been reported previously in at least two individuals with metatropic dysplasia, one of whom had a lethal phenotype and the other of whom had a non-lethal phenotype but was found to have the L618P variant in the mosaic state (Camacho et al., 2010; Weinstein et al., 2016). Functional studies demonstrate that L618P is associated with TRPV4 channel over-activity (Loukin et al., 2011). The L618P variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The L618P variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. We interpret L618P as a pathogenic variant. -
Skeletal dysplasia Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at